irbesartan
Ligand Summary
A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
UNII: J0E2756Z7N
PubChem: 3749
Guide to Pharmacology: 6908
Guide to Pharmacology: 589
ChEMBL: CHEMBL1513
DrugCentral: 1481
LyCHI: 24QDP6NHFGA9
Target Activities
11 Activities
Items per page:
1 – 10 of 11
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
- | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||